Adial Pharmaceuticals Inc
ADIL
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.3M
Close$
$5.04
117.4% upside
Current Fair Value
117.4% upsideUndervalued by 117.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.30 Million |
|---|---|
| Enterprise Value | $-2,280,954.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-11.93 |
| Beta | 1.27 |
| Outstanding Shares | 1,370,109 |
Return
| Return on Equity | -209.05% |
|---|---|
| Return on Assets | -148.66% |
| Return on Invested Capital | -202.67% |
Valuation & Multiples
| P/E Ratio | -0.42 |
|---|---|
| PEG | 4.57 |
| Price to Sales | - |
| Price to Book Ratio | 1.16 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.3 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
$-2.25
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-1.06
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.20%▼ 12.75% |
|---|---|
| Total Invested | $63,627▼ 91.82% |
| Investors Holding | 14▼ 8.00% |
ESG Score
No data
About Adial Pharmaceuticals Inc
2,018 employees